Caldwell Sutter Capital, Inc. Glaukos Corp Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q4 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 3,913 shares of GKOS stock, worth $427,103. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,913
Previous 3,913
-0.0%
Holding current value
$427,103
Previous $510 Million
15.09%
% of portfolio
0.27%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
50.1MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$877 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$652 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$236 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$225 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$211 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.2B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...